Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v3.20.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Debt
At March 31, 2020 and December 31, 2019, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the 2025 Notes, the Credit Agreement and amounts outstanding under lines of credit described above) as follows:
(In thousands)
March 31,
2020
 
December 31,
2019
Current portion of notes payable
$
1,927

 
$
2,494

Other long-term liabilities
4,291

 
4,723

Total
$
6,218

 
$
7,217


The following table sets forth information related to the 2025 Notes which is included in our Condensed Consolidated Balance Sheet as of March 31, 2020:
(In thousands)
2025 Senior Notes
 
Discount
 
Debt Issuance Cost
 
Total
Balance at December 31, 2019
$
200,000

 
$
(46,774
)
 
$
(5,086
)
 
$
148,140

Amortization of debt discount and debt issuance costs
—

 
1,724

 
188

 
1,912

Balance at March 31, 2020
$
200,000

 
$
(45,050
)
 
$
(4,898
)
 
$
150,052


Summary of Lines of Credit
The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings at March 31, 2020
 
Credit line
capacity
 
March 31,
2020
 
December 31,
2019
JPMorgan Chase
 
3.55%
 
$
75,000

 
$
39,311

 
$
44,750

Itau Bank
 
5.50%
 
1,810

 
565

 
472

Bank of Chile
 
6.60%
 
3,800

 
950

 
851

BICE Bank
 
5.50%
 
2,500

 
896

 
1,429

BBVA Bank
 
5.50%
 
3,250

 
—

 
11

Security Bank
 
5.50%
 
489

 
489

 
588

Estado Bank
 
5.50%
 
3,500

 
2,109

 
1,365

Santander Bank
 
5.50%
 
4,500

 
3,186

 
1,943

Scotiabank
 
5.00%
 
1,800

 
1,664

 
668

Corpbanca
 
5.00%
 
1,017

 
1,017

 
—

Banco De Sabadell
 
1.30%
 
330

 
—

 
—

Banco Bilbao Vizcaya
 
1.70%
 
330

 
—

 
—

Banco Santander
 
1.40%
 
330

 
—

 
—

Total
 
 
 
$
98,656

 
$
50,187

 
$
52,077